Ayurvedic intervention on Diabetes induced eye disease causing vision loss.

Role of Madhuyastyadi Guggulu in the management of Diabetic Retinopathy

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019038

Enrollment

Registered

2019-05-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes Health Condition 2: null- Diabetic patients with features of Diabetic Retinopathy

Interventions

Intervention1: Group I:Trial group Group II:Control group: Group I:Trial drug 500mg 2tab tds for 3month. Group II:Placebo drug Control Intervention1: placebo: placebo

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic patients with TypeI or TypeII diabetes mellitus with 5 or more years duration. Patients with features of diabetic retinopathy with diabetic macular oedema(without any high risk characteristics) on examination.

Exclusion criteria

Exclusion criteria: 1.Patients with other type of vascular retinopathies like gestational diabetic retinopathy,hypertensive retinopathy etc. 2.If patient develops any complications to treatment. 3.Patients with intravitreal injection ,operation within 3 month duration of the first visit. 4.Patient not giving consent for study.

Design outcomes

Primary

Measure	Time frame
Improvement of vision Decrease in Diabetic Macular Oedema Improvement in signs and symptoms of diabetic retinopathyTimepoint: 0,1month,2month,3month,4month	—

Secondary

Measure	Time frame
Decrease in Diabetic Macular oedemaTimepoint: 0,1month,2month,3month,4month,5and 6month follow up	—

Countries

India

Contacts

Public ContactDr Priyanka Joshi

B.H.U

joshipbhu@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026